109 related articles for article (PubMed ID: 8501010)
1. A new antibiotic, structurally related to leptomycin A, flattens the morphology of v-ras(ts) NRK cells.
Hosokawa N; Iinuma H; Naganawa H; Hamada M; Takeuchi T; Itoh T; Hori M
J Antibiot (Tokyo); 1993 Apr; 46(4):676-8. PubMed ID: 8501010
[No Abstract] [Full Text] [Related]
2. Total synthesis of reveromycin A.
Shimizu T; Masuda T; Hiramoto K; Nakata T
Org Lett; 2000 Jul; 2(14):2153-6. PubMed ID: 10891254
[TBL] [Abstract][Full Text] [Related]
3. First stereoselective total synthesis of FD-594 aglycon.
Masuo R; Ohmori K; Hintermann L; Yoshida S; Suzuki K
Angew Chem Int Ed Engl; 2009; 48(19):3462-5. PubMed ID: 19347912
[TBL] [Abstract][Full Text] [Related]
4. Change of ras-transformed NRK-cells back to normal morphology by mycalamides A and B, antitumor agents from a marine sponge.
Ogawara H; Higashi K; Uchino K; Perry NB
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2152-4. PubMed ID: 1797440
[TBL] [Abstract][Full Text] [Related]
5. A new anthracycline antibiotic, IT-62-B, converts the morphology of ras-transformed cells back to normal: taxonomy, fermentation, isolation, structure elucidation and biological characterization.
Kawauchi T; Sasaki T; Yoshida K; Matsumoto H; Chen RX; Huang MY; Tsuchiya KS; Otani T
J Antibiot (Tokyo); 1997 Apr; 50(4):297-303. PubMed ID: 9186553
[TBL] [Abstract][Full Text] [Related]
6. Anguinomycins C and D, new antitumor antibiotics with selective cytotoxicity against transformed cells.
Hayakawa Y; Sohda KY; Shin-Ya K; Hidaka T; Seto H
J Antibiot (Tokyo); 1995 Sep; 48(9):954-61. PubMed ID: 7592062
[TBL] [Abstract][Full Text] [Related]
7. Participation of the beta-hydroxyketone part for potent cytotoxicity of callystatin A, a spongean polyketide.
Murakami N; Sugimoto M; Kobayashi M
Bioorg Med Chem; 2001 Jan; 9(1):57-67. PubMed ID: 11197346
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a new pyrano[4',3':6,7]naphtho[1,2-b]xanthene antibiotic FD-594.
Qiao YF; Okazaki T; Ando T; Mizoue K
J Antibiot (Tokyo); 1998 Mar; 51(3):282-7. PubMed ID: 9589063
[TBL] [Abstract][Full Text] [Related]
9. Pyrylium monolayers as amino-reactive platform.
Scaramuzzo FA; González-Campo A; Wu CC; Velders AH; Subramaniam V; Doddi G; Mencarelli P; Barteri M; Jonkheijm P; Huskens J
Chem Commun (Camb); 2010 Jun; 46(23):4193-5. PubMed ID: 20458426
[TBL] [Abstract][Full Text] [Related]
10. FR901464: total synthesis, proof of structure, and evaluation of synthetic analogues.
Thompson CF; Jamison TF; Jacobsen EN
J Am Chem Soc; 2001 Oct; 123(41):9974-83. PubMed ID: 11592876
[TBL] [Abstract][Full Text] [Related]
11. Participation of the conjugated diene part for potent cytotoxicity of callystatin A, a spongean polyketide.
Murakami N; Sugimoto M; Nakajima T; Kawanishi M; Tsutsui Y; Kobayashi M
Bioorg Med Chem; 2000 Nov; 8(11):2651-61. PubMed ID: 11092550
[TBL] [Abstract][Full Text] [Related]
12. Chemical and biological studies of reveromycin A.
Osada H
J Antibiot (Tokyo); 2016 Oct; 69(10):723-730. PubMed ID: 27270304
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of leptomycin B.
Komiyama K; Okada K; Tomisaka S; Umezawa I; Hamamoto T; Beppu T
J Antibiot (Tokyo); 1985 Mar; 38(3):427-9. PubMed ID: 4008334
[No Abstract] [Full Text] [Related]
14. Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
Shimizu T; Usui T; Fujikura M; Kawatani M; Satoh T; Machida K; Kanoh N; Woo JT; Osada H; Sodeoka M
Bioorg Med Chem Lett; 2008 Jul; 18(13):3756-60. PubMed ID: 18519164
[TBL] [Abstract][Full Text] [Related]
15. Leptostatin: a synthetic hybrid of the cytotoxic polyketides callystatin A and leptomycin B.
Marshall JA; Mikowski AM; Bourbeau MP; Schaaf GM; Valeriote F
Bioorg Med Chem Lett; 2006 Jan; 16(2):320-3. PubMed ID: 16271470
[TBL] [Abstract][Full Text] [Related]
16. A new antitumor antibiotic, BE-19412A, produced by a streptomycete.
Tsukamoto M; Nakajima S; Arakawa H; Sugiura Y; Suzuki H; Hirayama M; Kamiya S; Teshima Y; Kondo H; Kojiri K; Suda H
J Antibiot (Tokyo); 1998 Oct; 51(10):908-14. PubMed ID: 9917003
[TBL] [Abstract][Full Text] [Related]
17. Lactimidomycin, a new glutarimide group antibiotic. Production, isolation, structure and biological activity.
Sugawara K; Nishiyama Y; Toda S; Komiyama N; Hatori M; Moriyama T; Sawada Y; Kamei H; Konishi M; Oki T
J Antibiot (Tokyo); 1992 Sep; 45(9):1433-41. PubMed ID: 1429229
[TBL] [Abstract][Full Text] [Related]
18. Dutomycin, a new anthracycline antibiotic from Streptomyces.
Xuan LJ; Xu SH; Zhang HL; Xu YM; Chen MQ
J Antibiot (Tokyo); 1992 Dec; 45(12):1974-6. PubMed ID: 1490891
[No Abstract] [Full Text] [Related]
19. Screening of antibiotics preferentially active against ras oncogene-expressed cells.
Suzukake-Tsuchiya K; Moriya Y; Yamazaki K; Hori M; Hosokawa N; Sawa T; Iinuma H; Naganawa H; Imada C; Hamada M
J Antibiot (Tokyo); 1990 Nov; 43(11):1489-96. PubMed ID: 2272923
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of novel thioester derivatives of leinamycin.
Kanda Y; Ashizawa T; Kakita S; Takahashi Y; Kono M; Yoshida M; Saitoh Y; Okabe M
J Med Chem; 1999 Apr; 42(8):1330-2. PubMed ID: 10212117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
